The cystine/glutamate antiporter system xc - in health and disease: From molecular mechanisms to novel therapeutic opportunities

Jan Lewerenz, Sandra J. Hewett, Ying Huang, Maria Lambros, Peter W. Gout, Peter W. Kalivas, Ann Massie, Ilse Smolders, Axel Methner, Mathias Pergande, Sylvia B Smith, Vadivel Ganapathy, Pamela Maher

Research output: Contribution to journalReview article

239 Citations (Scopus)

Abstract

The antiporter system xc - imports the amino acid cystine, the oxidized form of cysteine, into cells with a 1:1 counter-transport of glutamate. It is composed of a light chain, xCT, and a heavy chain, 4F2 heavy chain (4F2hc), and, thus, belongs to the family of heterodimeric amino acid transporters. Cysteine is the rate-limiting substrate for the important antioxidant glutathione (GSH) and, along with cystine, it also forms a key redox couple on its own. Glutamate is a major neurotransmitter in the central nervous system (CNS). By phylogenetic analysis, we show that system xc - is a rather evolutionarily new amino acid transport system. In addition, we summarize the current knowledge regarding the molecular mechanisms that regulate system xc -, including the transcriptional regulation of the xCT light chain, posttranscriptional mechanisms, and pharmacological inhibitors of system xc -. Moreover, the roles of system xc - in regulating GSH levels, the redox state of the extracellular cystine/cysteine redox couple, and extracellular glutamate levels are discussed. In vitro, glutamate-mediated system x c - inhibition leads to neuronal cell death, a paradigm called oxidative glutamate toxicity, which has successfully been used to identify neuroprotective compounds. In vivo, xCT has a rather restricted expression pattern with the highest levels in the CNS and parts of the immune system. System xc - is also present in the eye. Moreover, an elevated expression of xCT has been reported in cancer. We highlight the diverse roles of system xc - in the regulation of the immune response, in various aspects of cancer and in the eye and the CNS.

Original languageEnglish (US)
Pages (from-to)522-555
Number of pages34
JournalAntioxidants and Redox Signaling
Volume18
Issue number5
DOIs
StatePublished - Feb 10 2013

Fingerprint

Antiporters
Cystine
Glutamic Acid
Health
Neurology
Oxidation-Reduction
Cysteine
Amino Acid Transport Systems
Central Nervous System
CD98 Heavy Chain Antigens
Eye Neoplasms
Therapeutics
Light
Immune system
Cell death
Glutathione
Neurotransmitter Agents
Toxicity
Immune System
Cell Death

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

The cystine/glutamate antiporter system xc - in health and disease : From molecular mechanisms to novel therapeutic opportunities. / Lewerenz, Jan; Hewett, Sandra J.; Huang, Ying; Lambros, Maria; Gout, Peter W.; Kalivas, Peter W.; Massie, Ann; Smolders, Ilse; Methner, Axel; Pergande, Mathias; Smith, Sylvia B; Ganapathy, Vadivel; Maher, Pamela.

In: Antioxidants and Redox Signaling, Vol. 18, No. 5, 10.02.2013, p. 522-555.

Research output: Contribution to journalReview article

Lewerenz, J, Hewett, SJ, Huang, Y, Lambros, M, Gout, PW, Kalivas, PW, Massie, A, Smolders, I, Methner, A, Pergande, M, Smith, SB, Ganapathy, V & Maher, P 2013, 'The cystine/glutamate antiporter system xc - in health and disease: From molecular mechanisms to novel therapeutic opportunities', Antioxidants and Redox Signaling, vol. 18, no. 5, pp. 522-555. https://doi.org/10.1089/ars.2011.4391
Lewerenz, Jan ; Hewett, Sandra J. ; Huang, Ying ; Lambros, Maria ; Gout, Peter W. ; Kalivas, Peter W. ; Massie, Ann ; Smolders, Ilse ; Methner, Axel ; Pergande, Mathias ; Smith, Sylvia B ; Ganapathy, Vadivel ; Maher, Pamela. / The cystine/glutamate antiporter system xc - in health and disease : From molecular mechanisms to novel therapeutic opportunities. In: Antioxidants and Redox Signaling. 2013 ; Vol. 18, No. 5. pp. 522-555.
@article{1db52d50248547e9a19f089c810f802a,
title = "The cystine/glutamate antiporter system xc - in health and disease: From molecular mechanisms to novel therapeutic opportunities",
abstract = "The antiporter system xc - imports the amino acid cystine, the oxidized form of cysteine, into cells with a 1:1 counter-transport of glutamate. It is composed of a light chain, xCT, and a heavy chain, 4F2 heavy chain (4F2hc), and, thus, belongs to the family of heterodimeric amino acid transporters. Cysteine is the rate-limiting substrate for the important antioxidant glutathione (GSH) and, along with cystine, it also forms a key redox couple on its own. Glutamate is a major neurotransmitter in the central nervous system (CNS). By phylogenetic analysis, we show that system xc - is a rather evolutionarily new amino acid transport system. In addition, we summarize the current knowledge regarding the molecular mechanisms that regulate system xc -, including the transcriptional regulation of the xCT light chain, posttranscriptional mechanisms, and pharmacological inhibitors of system xc -. Moreover, the roles of system xc - in regulating GSH levels, the redox state of the extracellular cystine/cysteine redox couple, and extracellular glutamate levels are discussed. In vitro, glutamate-mediated system x c - inhibition leads to neuronal cell death, a paradigm called oxidative glutamate toxicity, which has successfully been used to identify neuroprotective compounds. In vivo, xCT has a rather restricted expression pattern with the highest levels in the CNS and parts of the immune system. System xc - is also present in the eye. Moreover, an elevated expression of xCT has been reported in cancer. We highlight the diverse roles of system xc - in the regulation of the immune response, in various aspects of cancer and in the eye and the CNS.",
author = "Jan Lewerenz and Hewett, {Sandra J.} and Ying Huang and Maria Lambros and Gout, {Peter W.} and Kalivas, {Peter W.} and Ann Massie and Ilse Smolders and Axel Methner and Mathias Pergande and Smith, {Sylvia B} and Vadivel Ganapathy and Pamela Maher",
year = "2013",
month = "2",
day = "10",
doi = "10.1089/ars.2011.4391",
language = "English (US)",
volume = "18",
pages = "522--555",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - The cystine/glutamate antiporter system xc - in health and disease

T2 - From molecular mechanisms to novel therapeutic opportunities

AU - Lewerenz, Jan

AU - Hewett, Sandra J.

AU - Huang, Ying

AU - Lambros, Maria

AU - Gout, Peter W.

AU - Kalivas, Peter W.

AU - Massie, Ann

AU - Smolders, Ilse

AU - Methner, Axel

AU - Pergande, Mathias

AU - Smith, Sylvia B

AU - Ganapathy, Vadivel

AU - Maher, Pamela

PY - 2013/2/10

Y1 - 2013/2/10

N2 - The antiporter system xc - imports the amino acid cystine, the oxidized form of cysteine, into cells with a 1:1 counter-transport of glutamate. It is composed of a light chain, xCT, and a heavy chain, 4F2 heavy chain (4F2hc), and, thus, belongs to the family of heterodimeric amino acid transporters. Cysteine is the rate-limiting substrate for the important antioxidant glutathione (GSH) and, along with cystine, it also forms a key redox couple on its own. Glutamate is a major neurotransmitter in the central nervous system (CNS). By phylogenetic analysis, we show that system xc - is a rather evolutionarily new amino acid transport system. In addition, we summarize the current knowledge regarding the molecular mechanisms that regulate system xc -, including the transcriptional regulation of the xCT light chain, posttranscriptional mechanisms, and pharmacological inhibitors of system xc -. Moreover, the roles of system xc - in regulating GSH levels, the redox state of the extracellular cystine/cysteine redox couple, and extracellular glutamate levels are discussed. In vitro, glutamate-mediated system x c - inhibition leads to neuronal cell death, a paradigm called oxidative glutamate toxicity, which has successfully been used to identify neuroprotective compounds. In vivo, xCT has a rather restricted expression pattern with the highest levels in the CNS and parts of the immune system. System xc - is also present in the eye. Moreover, an elevated expression of xCT has been reported in cancer. We highlight the diverse roles of system xc - in the regulation of the immune response, in various aspects of cancer and in the eye and the CNS.

AB - The antiporter system xc - imports the amino acid cystine, the oxidized form of cysteine, into cells with a 1:1 counter-transport of glutamate. It is composed of a light chain, xCT, and a heavy chain, 4F2 heavy chain (4F2hc), and, thus, belongs to the family of heterodimeric amino acid transporters. Cysteine is the rate-limiting substrate for the important antioxidant glutathione (GSH) and, along with cystine, it also forms a key redox couple on its own. Glutamate is a major neurotransmitter in the central nervous system (CNS). By phylogenetic analysis, we show that system xc - is a rather evolutionarily new amino acid transport system. In addition, we summarize the current knowledge regarding the molecular mechanisms that regulate system xc -, including the transcriptional regulation of the xCT light chain, posttranscriptional mechanisms, and pharmacological inhibitors of system xc -. Moreover, the roles of system xc - in regulating GSH levels, the redox state of the extracellular cystine/cysteine redox couple, and extracellular glutamate levels are discussed. In vitro, glutamate-mediated system x c - inhibition leads to neuronal cell death, a paradigm called oxidative glutamate toxicity, which has successfully been used to identify neuroprotective compounds. In vivo, xCT has a rather restricted expression pattern with the highest levels in the CNS and parts of the immune system. System xc - is also present in the eye. Moreover, an elevated expression of xCT has been reported in cancer. We highlight the diverse roles of system xc - in the regulation of the immune response, in various aspects of cancer and in the eye and the CNS.

UR - http://www.scopus.com/inward/record.url?scp=84872191631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872191631&partnerID=8YFLogxK

U2 - 10.1089/ars.2011.4391

DO - 10.1089/ars.2011.4391

M3 - Review article

C2 - 22667998

AN - SCOPUS:84872191631

VL - 18

SP - 522

EP - 555

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 5

ER -